CSSi LifeSciencesTM Working Together



We are uniquely positioned to provide a comprehensive and scalable suite of services to develop therapeutic drugs and devices with cost-efficient predictability. We have the expertise to support lifecycle strategies that drive product value, extend market share, and maximize ROI.

Avoid the “large CRO shuffle” – We offer cost efficient, fully integrated expertise and services from start to finish.

NAVIGATING YOUR PATHWAY TO SUCCESS

Crossing 'the vally of death'

We bridge the
“Valley of Death”
and accelerate research
breakthroughs

Our unique SmartStart™ Access program lets companies leverage our existing suite of integrated services and growth strategies to develop and commercialize products.

UNPARALLELED SUCCESS FROM DISCOVERY TO COMMERCIALIZATION

  • Commercialized over 500 new drugs, biologics, medical devices and in-vitro diagnostics
  • Over 250 medical device 510(k) Class 1-3 submissions with 100% success
  • Extensive Orphan, “First in Class,” and “First In” Indication success.
  • Reduced time to approval by over 600 days
  • Over 100 NDA, ANDA and BLA submissions, with 96% success
  • Greater than 60 EMA CHMP Marketing Authorizations
  • SmartStudy™ design and feasibility assessments enhanced study efficiency and success and reduced protocol amendments by over 50%